手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| 慢性心不全質問票× | COPDアセスメントテスト× | |
|---|---|---|
| 分野 | 健康アウトカム | 健康アウトカム |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 2000 | 2009 |
| 提唱者≠ | Luc Guyonnet et al. | Paul W. Jones et al. |
| 種類≠ | Self-report quality of life questionnaire | Self-report symptom and impact questionnaire |
| 原典≠ | Guyonnet, S., Vellas, B., Garry, P. J., & Albarede, J. L. (2000). The Chronic Heart Failure Questionnaire: A pilot study of validity, reliability, and responsiveness. Journal of Cardiac Failure, 6(1), 21-26. link ↗ | Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W. H., & Kline Leidy, N. (2009). Development and first validation of the COPD Assessment Test. European Respiratory Journal, 34(3), 648-654. DOI ↗ |
| 別名 | CHQ, Heart Failure Quality of Life, Chronic Heart Failure QoL | CAT, COPD Assessment Test, COPD Assessment Tool |
| 関連 | 4 | 4 |
| 概要≠ | The CHQ is a disease-specific quality of life measure for chronic heart failure (CHF). Developed by Luc Guyonnet and colleagues in 2000, this 20-item questionnaire assesses how heart failure affects dyspnea, fatigue, emotional function, and activity limitation. It is used in heart failure clinical trials and research to quantify patient-experienced burden and treatment benefit. | The COPD Assessment Test (CAT) is a simple, rapid, patient-centered measure of COPD symptom burden and functional impact. Developed by Paul Jones and colleagues in 2009, this 8-item questionnaire captures how COPD affects cough, sputum, chest tightness, breathing difficulty, activity limitation, confidence, sleep, and energy. It is used worldwide in clinical practice to guide disease management decisions and as a primary outcome measure in COPD clinical trials. |
| ScholarGateデータセット ↗ |
|
|